Newsletter Archive

31. 06.24.26 -- What's Driving Cell & Gene Therapy Forward? Key Trends & Insights 6/24/2026

    06/24/26 Bioprocess Online Newsletter

32. 06.24.26 -- Reduce Scale-Up Surprises and Accelerate Development Timelines 6/24/2026

    06/24/26 Bioprocess Online Newsletter

33. 06.24.26 -- Affinity Membranes Are Moving Closer To Commercial Reality 6/24/2026
    06/24/26 Bioprocess Online Newsletter
34. 06.23.26 -- At BIO this week? Here are ADC & AOC Insights You Need 6/23/2026

    06/23/26 Bioprocess Online Newsletter

35. 06.23.26 -- Smarter risk management for single-use and filtration systems. 6/23/2026

    06/23/26 Bioprocess Online Newsletter

36. 06.23.26 -- Avoiding Common Pitfalls In CDMO–Sponsor Relationships Through Integrated Execution Models 6/23/2026
    06/23/26 Bioprocess Online Newsletter
37. 06.22.26 -- On The Ground At NextGen Biomed 2026 6/22/2026
    06/22/26
38. 06.22.26 -- Simplify The Journey Of Advancing Your Therapies To Patients 6/22/2026

    06/22/26 Bioprocess Online Newsletter

39. 06.20.26 -- FDA Codifies CMC Flexibility For CGTs, Assay Selection, And Comparing Analytical-Validation Guidelines 6/20/2026
    06/20/26 Bioprocess Online Newsletter
40. 06.19.26 -- STREAM Edition: Democratizing Digital Tools 6/19/2026

    06/19/26 Bioprocess Online Newsletter